Apnoea has been recognised as a major problem in many preterm and some full term infants before discharge from the nursery.' 2 Evaluation in these infants usually fails to identify any underlying cause for the attacks of apnoea. Prolonged attacks of apnoea, especially in premature infants, are apparently not predictive of sudden infant death syndrome1 3 but are often perceived by parents and physicians as a life threatening event with a risk of recurrence. Home monitoring has therefore been suggested in the management of these infants with unexplained apnoeic or cyanotic episodes.4 5 In addition, treatment with theophylline has also been found to be an effective adjunct in the care of these infants.6 7 Apnoea of prematurity can be treated with caffeine,8 which has a wider safety margin than theophylline.9 While the two abnormalities in the control of ventilation-that is, apnoea of prematurity and persistent infantile apnoea-may result from different mechanisms, we hypothesised that caffeine may be better suited for home use. As no systematic evaluation of caffeine has been performed in home circumstances we decided to evaluate the effect of home administration of caffeine on breathing patterns as measured by 12 891 hour pneumogram and on the incidence of clinically important apnoea.
Subjects and methods
We studied 19 preterm infants ready for discharge from the newborn nursery who were administration of caffeine is shown in Table 2 . Also contrasted in this Table  3 . Eleven infants became free of attacks of apnoea after administration of caffeine. Twelve infants continued to have short attacks, none of whom, however, had prolonged attacks (over 15 seconds in duration) or attacks associated with bradycardia. Also shown in Table 3 is the number of infants with periodic breathing in excess of 3-5% and apnoea density in excess of 1-5% in relation to treatment with caffeine. While these cut off values for excessive periodic breathing and apnoea density are not totally discriminative, infants with apnoea of infancy generally have values above and normal infants below these cut off values.1 l The reduction in the number of infants with attacks of apnoea in all categories and excessive periodic breathing after adminsitration of caffeine is significant except for attacks lasting 11-15 seconds. The reduction in the number of infants with apnoea density over 1-5% in relation to administration of caffeine is not significant.
Home evaluation of our study infants showed that false alarms on the monitors were common. These alarms were related to loose leads and short episodes of bradycardia lasting less than 3-5 seconds (perhaps related to transient vagal stimulation). None of our study infants, however, had prolonged attacks of apnoea (over 15 seconds) or attacks associated with colour change or bradycardia requiring intervention (manual stimulation or mouth to mouth ventilation) while on caffeine. Two infants became irritable, restless, and jittery after starting treatment with caffeine. These symptoms resolved after stopping treatment with caffeine, and subsequently theophylline was well tolerated by them. Theophylline was administered to these infants one to two weeks after the second pneumogram and so did not affect the pneumogram analysis. The remaining 21 infants received caffeine for 3-4 (1.3) months. Seventeen infants had no obvious harmful effects related to caffeine. Four infants were judged by their parents to be somewhat more irritable and restless while on caffeine. Their daily activity, sleep, 
Discussion
Most parents display anxiety at the prospect of caring for their infants who suffer from attacks of apnoea at home. Home monitoring is currently an accepted way of managing infants with attacks of apnoea. The ability of anxious parents to deal with an attack of apnoea detected by the monitor is, however, variable. Infants have been known to die of sudden infant death syndrome at home while being monitored.12 Death at home in these monitored infants may be due either to the fact that sudden infant death syndrome is not preventable or to the inability of the parents to provide adequate resuscitation. Implicit in the home monitoring of infants with attacks of apnoea is the idea that parents can learn the skills of resuscitation and execute them when needed. To date this assumption is untested and unproven. It is important, therefore, to prevent prolonged attacks of apnoea at home that may require intervention.
Respirogenic properties of the methylxanthines, particularly caffeine, have been known for a long time. infants with attacks of apnoea studied at 7-7 (7-1) weeks compared with control infants at 1 and 3 months of age." From these studies we conclude that infants with attacks of apnoea have persistent breathing pattern abnormalities that are not likely to resolve spontaneously within seven to 10 days. This conclusion is supported by the findings in two of our study infants who developed side effects from treatment with caffeine that necessitated stopping this drug after one week in one infant and two weeks group.bmj.com on November 8, 2017 -Published by http://adc.bmj.com/ Downloaded from in the other. Both of these infants had a recurrence of apnoea requiring intervention.
In conclusion, our data show that caffeine improves pneumogram abnormalities in infants suffering from attacks of apnoea. In addition, this improvement in pneumogram findings is associated with resolution of clinically important apnoea requiring intervention.
